ASHLEY WALPOLE: Open Payments
NPI 1164804936 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 68 payments from 10 companies in 2025. Trend: 2023 $838 · 2024 $1,297 · 2025 $1,375
Food & beverage: $1,375
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 28 | $546 |
| AstraZeneca Pharmaceuticals LP | 17 | $367 |
| Insmed, Inc. | 10 | $145 |
| Regeneron Healthcare Solutions, Inc. | 4 | $126 |
| Verona Pharma, Inc. | 3 | $75 |
| Viatris Specialty LLC | 2 | $42 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Boston Scientific Corporation | 1 | $17 |
| Itamar Medical Inc | 1 | $11 |
Products named: NUCALA, TRELEGY ELLIPTA, BREZTRI, Arikayce, DUPIXENT, AIRSUPRA, Ohtuvayre, TEZSPIRE.
Industry payments across LA — which companies pay providers there.
